REPORT ID 141071

Pulmonary or Respiratory Drug Delivery Market - Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Forecasts & Competition Tracking - Global Market Insights 2020 to 2028

Publish Date
Feb-21
Pages
250
Format
Electronic (PDF)

According to Healthcare Intelligence Markets, the Pulmonary or Respiratory Drug Delivery market was valued at US$ xx million in 2019 and is expected to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on the Pulmonary or Respiratory Drug Delivery market offers in-depth analysis covering key regional trends, market dynamics, and provides country-level market size of the Pulmonary or Respiratory Drug Delivery industry. Some of the key factors considered during the course of research included product definition, product classification, industry structure, various participants in the Pulmonary or Respiratory Drug Delivery ecosystem, etc. The report includes market sizes and forecast for the period from 2020 to 2028, and compounded annual growth rate (CAGR%) measured for individual segments and regional markets, competitive landscape of leading market players, critical analysis of market dynamics and profiling of key providers participating in the Pulmonary or Respiratory Drug Delivery market.

The following manufacturers are covered in this report:
PARI Roche Sunovion Pharmaceuticals. AptarGroup S. A. Teva Pharmaceutical TTP plc Hovione OMRON Group GF Health Products Inc. GlaxoSmithKline Pharma GmbH , Progressive Trade Media Limited AstraZeneca BeyonDevice Merck 3M, Aphios Corporation Cipla Philips Novartis Catalent Pharma Solutions Boehringer Ingelheim

Since the onset of COVID-19 in December 2019, numerous economies around the globe experienced severe economic downturn due to the unexpected lockdowns and halt in international trade. The impact of COVID-19 on the Pulmonary or Respiratory Drug Delivery market was witnessed since early 2020. The report aims to provide the pre-COVID-19 state of the Pulmonary or Respiratory Drug Delivery market in years 2018 and 2019 and further provide forecast for the COVID-19 period from 2020 to 2028 so that businesses operating in the Pulmonary or Respiratory Drug Delivery market would have insights in the future outlook of the market.

Report Scope: Pulmonary or Respiratory Drug Delivery Market
This report provides an investigative analysis of the Pulmonary or Respiratory Drug Delivery market encapsulated in detailed sections such as
Pulmonary or Respiratory Drug Delivery Market Overview
Major Commercial Developments in the Pulmonary or Respiratory Drug Delivery Industry
Market Dynamics Impacting the Pulmonary or Respiratory Drug Delivery Industry
Competitive Landscape of Pulmonary or Respiratory Drug Delivery Industry
Positioning of Major Market Participants in the Pulmonary or Respiratory Drug Delivery Industry
Key Market Trends and Future Growth Prospects of the Pulmonary or Respiratory Drug Delivery Market
Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast, by Type, 2018 - 2028
Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast, by Application, 2018 - 2028
Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast, by End-use, 2018 - 2028
Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast, by Geography, 2018 - 2028

Pulmonary or Respiratory Drug Delivery Market Segmentation:
The report offers in-depth analysis of the Pulmonary or Respiratory Drug Delivery market based on various segments such as type, application and end-use industry. The Pulmonary or Respiratory Drug Delivery market is segmented as follows:

Pulmonary or Respiratory Drug Delivery Market, by Type:
Dry Powder Inhalers (DPIS)
Nebulizers

Pulmonary or Respiratory Drug Delivery Market, by Application:
Hospitals & Clinics
Home Care Settings

Geographic Coverage
The report on the Pulmonary or Respiratory Drug Delivery market provides a detailed country-level cross-sectional analysis across various regions around the globe. The report contains detailed market size and forecast for the following countries and regions:

North America Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast
U.S.
Canada

Europe Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast
UK
Germany
France
Rest of Europe

Asia Pacific Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast
China
Japan
India
Rest of Asia Pacific

Latin America Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast
Mexico
Brazil
Rest of Latin America

Middle East and Africa Pulmonary or Respiratory Drug Delivery Market Revenue and Forecast
GCC Countries
South Africa
Rest of Middle East and Africa
The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain in the air bearing spindle market. The report provide in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on air bearing spindle market segments and geographies.

Report Highlights:

Detailed overview of air bearing spindle market
Changing air bearing spindle market dynamics in the industry
In-depth market segmentation
Historical, current, and projected air bearing spindle market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on air bearing spindle market performance
Must-have information for air bearing spindle market players to sustain and enhance their market footprint
Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
			   
1 Pulmonary or Respiratory Drug Delivery Market Overview
       1.1 Product Overview and Scope of Pulmonary or Respiratory Drug Delivery
       1.2 Pulmonary or Respiratory Drug Delivery Segment by Type
               1.2.1 Global Pulmonary or Respiratory Drug Delivery Sales Growth Rate Comparison by Type (2020-2026)
               1.2.2 Product Dry Powder Inhalers (DPIS)
               1.2.3 Product Nebulizers
               1.2.4 Product Type 3
               1.2.5 Others
       1.3 Pulmonary or Respiratory Drug Delivery Segment by Application
               1.3.1 Pulmonary or Respiratory Drug Delivery Sales Comparison by Application: (2020-2026)
               1.3.2 Hospitals & Clinics
               1.3.3 Home Care Settings
               1.3.4 Application 3
               1.3.5 Others
       1.4 Global Pulmonary or Respiratory Drug Delivery Market Size Estimates and Forecasts
               1.4.1 Global Pulmonary or Respiratory Drug Delivery Revenue 2015-2026
               1.4.2 Global Pulmonary or Respiratory Drug Delivery Sales 2015-2026
               1.4.3 Pulmonary or Respiratory Drug Delivery Market Size by Region: 2020 Versus 2026
       1.5 Coronavirus Disease 2019 (Covid-19): Pulmonary or Respiratory Drug Delivery Industry Impact
               1.5.1 How the Covid-19 is Affecting the Pulmonary or Respiratory Drug Delivery Industry
                            1.5.1.1 Pulmonary or Respiratory Drug Delivery Business Impact Assessment - Covid-19
                            1.5.1.2 Supply Chain Challenges
                            1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
               1.5.2 Market Trends and Pulmonary or Respiratory Drug Delivery Potential Opportunities in the COVID-19 Landscape
               1.5.3 Measures/Proposal against Covid-19
                            1.5.3.1 Government Measures to Combat Covid-19 Impact
                            1.5.3.2 Proposal for Pulmonary or Respiratory Drug Delivery Players to Combat Covid-19 Impact
       1.6 Study Objectives
       1.7 Years Considered

2 Global Pulmonary or Respiratory Drug Delivery Market Competition by Manufacturers
       2.1 Global Pulmonary or Respiratory Drug Delivery Sales Market Share by Manufacturers (2015-2020)
       2.2 Global Pulmonary or Respiratory Drug Delivery Revenue Share by Manufacturers (2015-2020)
       2.3 Global Pulmonary or Respiratory Drug Delivery Average Price by Manufacturers (2015-2020)
       2.4 Manufacturers Pulmonary or Respiratory Drug Delivery Manufacturing Sites, Area Served, Product Type
       2.5 Pulmonary or Respiratory Drug Delivery Market Competitive Situation and Trends
               2.5.1 Pulmonary or Respiratory Drug Delivery Market Concentration Rate
               2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
               2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
       2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
       2.7 Primary Interviews with Key Pulmonary or Respiratory Drug Delivery Players (Opinion Leaders)

3 Pulmonary or Respiratory Drug Delivery Retrospective Market Scenario by Region
       3.1 Global Pulmonary or Respiratory Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
       3.2 Global Pulmonary or Respiratory Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
       3.3 North America Pulmonary or Respiratory Drug Delivery Market Facts & Figures by Country
               3.3.1 North America Pulmonary or Respiratory Drug Delivery Sales by Country
               3.3.2 North America Pulmonary or Respiratory Drug Delivery Sales by Country
               3.3.3 U.S.
               3.3.4 Canada
       3.4 Europe Pulmonary or Respiratory Drug Delivery Market Facts & Figures by Country
               3.4.1 Europe Pulmonary or Respiratory Drug Delivery Sales by Country
               3.4.2 Europe Pulmonary or Respiratory Drug Delivery Sales by Country
               3.4.3 Germany
               3.4.4 France
               3.4.5 U.K.
               3.4.6 Italy
               3.4.7 Russia
       3.5 Asia Pacific Pulmonary or Respiratory Drug Delivery Market Facts & Figures by Region
               3.5.1 Asia Pacific Pulmonary or Respiratory Drug Delivery Sales by Region
               3.5.2 Asia Pacific Pulmonary or Respiratory Drug Delivery Sales by Region
               3.5.3 China
               3.5.4 Japan
               3.5.5 South Korea
               3.5.6 India
               3.5.7 Australia
               3.5.8 Taiwan
               3.5.9 Indonesia
               3.5.10 Thailand
               3.5.11 Malaysia
               3.5.12 Philippines
               3.5.13 Vietnam
       3.6 Latin America Pulmonary or Respiratory Drug Delivery Market Facts & Figures by Country
               3.6.1 Latin America Pulmonary or Respiratory Drug Delivery Sales by Country
               3.6.2 Latin America Pulmonary or Respiratory Drug Delivery Sales by Country
               3.6.3 Mexico
               3.6.4 Brazil
               3.6.5 Argentina
       3.7 Middle East and Africa Pulmonary or Respiratory Drug Delivery Market Facts & Figures by Country
               3.7.1 Middle East and Africa Pulmonary or Respiratory Drug Delivery Sales by Country
               3.7.2 Middle East and Africa Pulmonary or Respiratory Drug Delivery Sales by Country
               3.7.3 Turkey
               3.7.4 Saudi Arabia
               3.7.5 U.A.E
4 Global Pulmonary or Respiratory Drug Delivery Historic Market Analysis by Type
       4.1 Global Pulmonary or Respiratory Drug Delivery Sales Market Share by Type (2015-2020)
       4.2 Global Pulmonary or Respiratory Drug Delivery Revenue Market Share by Type (2015-2020)
       4.3 Global Pulmonary or Respiratory Drug Delivery Price Market Share by Type (2015-2020)
       4.4 Global Pulmonary or Respiratory Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Pulmonary or Respiratory Drug Delivery Historic Market Analysis by Application
       5.1 Global Pulmonary or Respiratory Drug Delivery Sales Market Share by Application (2015-2020)
       5.2 Global Pulmonary or Respiratory Drug Delivery Revenue Market Share by Application (2015-2020)
       5.3 Global Pulmonary or Respiratory Drug Delivery Price by Application (2015-2020)

6 Company Profiles and Key Figures in Pulmonary or Respiratory Drug Delivery Business
        6.1 PARI
                6.1.1 Corporation Information
                6.1.2 PARI Description, Business Overview
                6.1.3 PARI Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.1.4 PARI Products Offered
                6.1.5 PARI Recent Development
        6.2 Roche
                6.2.1 Corporation Information
                6.2.2 Roche Description, Business Overview
                6.2.3 Roche Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.2.4 Roche Products Offered
                6.2.5 Roche Recent Development
        6.3 Sunovion Pharmaceuticals.
                6.3.1 Corporation Information
                6.3.2 Sunovion Pharmaceuticals. Description, Business Overview
                6.3.3 Sunovion Pharmaceuticals. Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.3.4 Sunovion Pharmaceuticals. Products Offered
                6.3.5 Sunovion Pharmaceuticals. Recent Development
        6.4 AptarGroup S. A.
                6.4.1 Corporation Information
                6.4.2 AptarGroup S. A. Description, Business Overview
                6.4.3 AptarGroup S. A. Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.4.4 AptarGroup S. A. Products Offered
                6.4.5 AptarGroup S. A. Recent Development
        6.5 Teva Pharmaceutical
                6.5.1 Corporation Information
                6.5.2 Teva Pharmaceutical Description, Business Overview
                6.5.3 Teva Pharmaceutical Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.5.4 Teva Pharmaceutical Products Offered
                6.5.5 Teva Pharmaceutical Recent Development
        6.6 TTP plc
                6.6.1 Corporation Information
                6.6.2 TTP plc Description, Business Overview
                6.6.3 TTP plc Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.6.4 TTP plc Products Offered
                6.6.5 TTP plc Recent Development
        6.7 Hovione
                6.7.1 Corporation Information
                6.7.2 Hovione Description, Business Overview
                6.7.3 Hovione Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.7.4 Hovione Products Offered
                6.7.5 Hovione Recent Development
        6.8 OMRON Group
                6.8.1 Corporation Information
                6.8.2 OMRON Group Description, Business Overview
                6.8.3 OMRON Group Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.8.4 OMRON Group Products Offered
                6.8.5 OMRON Group Recent Development
        6.9 GF Health Products Inc.
                6.9.1 Corporation Information
                6.9.2 GF Health Products Inc. Description, Business Overview
                6.9.3 GF Health Products Inc. Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.9.4 GF Health Products Inc. Products Offered
                6.9.5 GF Health Products Inc. Recent Development
        6.10 GlaxoSmithKline Pharma GmbH ,
                6.10.1 Corporation Information
                6.10.2 GlaxoSmithKline Pharma GmbH , Description, Business Overview
                6.10.3 GlaxoSmithKline Pharma GmbH , Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.10.4 GlaxoSmithKline Pharma GmbH , Products Offered
                6.10.5 GlaxoSmithKline Pharma GmbH , Recent Development
        6.11 Progressive Trade Media Limited
                6.11.1 Corporation Information
                6.11.2 Progressive Trade Media Limited Description, Business Overview
                6.11.3 Progressive Trade Media Limited Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.11.4 Progressive Trade Media Limited Products Offered
                6.11.5 Progressive Trade Media Limited Recent Development
        6.12 AstraZeneca
                6.12.1 Corporation Information
                6.12.2 AstraZeneca Description, Business Overview
                6.12.3 AstraZeneca Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.12.4 AstraZeneca Products Offered
                6.12.5 AstraZeneca Recent Development
        6.13 BeyonDevice
                6.13.1 Corporation Information
                6.13.2 BeyonDevice Description, Business Overview
                6.13.3 BeyonDevice Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.13.4 BeyonDevice Products Offered
                6.13.5 BeyonDevice Recent Development
        6.14 Merck
                6.14.1 Corporation Information
                6.14.2 Merck Description, Business Overview
                6.14.3 Merck Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.14.4 Merck Products Offered
                6.14.5 Merck Recent Development
        6.15 3M,
                6.15.1 Corporation Information
                6.15.2 3M, Description, Business Overview
                6.15.3 3M, Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.15.4 3M, Products Offered
                6.15.5 3M, Recent Development
        6.16 Aphios Corporation
                6.16.1 Corporation Information
                6.16.2 Aphios Corporation Description, Business Overview
                6.16.3 Aphios Corporation Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.16.4 Aphios Corporation Products Offered
                6.16.5 Aphios Corporation Recent Development
        6.17 Cipla
                6.17.1 Corporation Information
                6.17.2 Cipla Description, Business Overview
                6.17.3 Cipla Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.17.4 Cipla Products Offered
                6.17.5 Cipla Recent Development
        6.18 Philips
                6.18.1 Corporation Information
                6.18.2 Philips Description, Business Overview
                6.18.3 Philips Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.18.4 Philips Products Offered
                6.18.5 Philips Recent Development
        6.19 Novartis
                6.19.1 Corporation Information
                6.19.2 Novartis Description, Business Overview
                6.19.3 Novartis Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.19.4 Novartis Products Offered
                6.19.5 Novartis Recent Development
        6.20 Catalent Pharma Solutions
                6.20.1 Corporation Information
                6.20.2 Catalent Pharma Solutions Description, Business Overview
                6.20.3 Catalent Pharma Solutions Pulmonary or Respiratory Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
                6.20.4 Catalent Pharma Solutions Products Offered
                6.20.5 Catalent Pharma Solutions Recent Development
    
7 Pulmonary or Respiratory Drug Delivery Manufacturing Cost Analysis
       7.1 Pulmonary or Respiratory Drug Delivery Key Raw Materials Analysis
              7.1.1 Key Raw Materials
              7.1.2 Key Raw Materials Price Trend
              7.1.3 Key Suppliers of Raw Materials
       7.2 Proportion of Manufacturing Cost Structure
       7.3 Manufacturing Process Analysis of Pulmonary or Respiratory Drug Delivery
       7.4 Pulmonary or Respiratory Drug Delivery Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
       8.1 Marketing Channel
       8.2 Pulmonary or Respiratory Drug Delivery Distributors List
       8.3 Pulmonary or Respiratory Drug Delivery Customers

9 Market Dynamics
        9.1 Market Overview
        9.2 Market Trends
        9.3 Market Inclination Insights Analysis
        9.4 Drivers
        9.5